IFRX revenueFY2025€29.3K
- FY YoY
- -82.3%
- 5Y CAGR
- -49.4%
IFRX revenue was €29.3K for fiscal 2025 (ended Dec 31, 2025), down 82.3% from fiscal 2024. Compound annual growth was -49.4% over 5 years.
InflaRx N.V. (IFRX) financials
For fiscal 2025 (ended Dec 31, 2025), InflaRx N.V. reported €29.3K of revenue and -€45.63M of net income. Figures are in EUR, the currency of its SEC filings.
- Revenue, FY2025
- €29.3K
- Revenue growth, YoY
- -82.3%
- Net income, FY2025
- -€45.63M
- Net margin
- -155582.1%
- Free cash flow, FY2025
- -€35.43M
- EPS, diluted, FY2025
- -€0.68
- Cash
- €16.02M
FY2016FY2025
FY2016FY2025
FY2020FY2025
IFRX revenue and earnings growth
IFRX net incomeFY2025-€45.63M
IFRX net income was -€45.63M for fiscal 2025 (ended Dec 31, 2025), compared with -€46.06M in fiscal 2024.
IFRX EPSFY2025-€0.68
IFRX diluted EPS was -€0.68 for fiscal 2025 (ended Dec 31, 2025), compared with -€0.78 in fiscal 2024.
IFRX free cash flowFY2025-€35.43M
IFRX free cash flow was -€35.43M for fiscal 2025 (ended Dec 31, 2025), compared with -€48.60M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €29.3K | €165.8K | €63.1K | -€32.24M | €109.4K | €887.7K | - | -€37.52M | -€19.45M | -€6.89M |
| Cost of revenue | €7.27M | €3.32M | €532.3K | - | - | - | - | - | - | - |
| Gross profit | -€7.24M | -€3.15M | -€469.2K | - | - | - | - | -€37.81M | -€19.55M | -€7.12M |
| Research and development | €25.72M | €35.36M | €41.02M | €37.53M | €35.70M | €25.68M | €44.58M | €25.03M | €14.41M | €5.28M |
| Selling, general and admin | €16.0K | €41.4K | €95.2K | €97.4K | €105.8K | €8.47M | €12.50M | €12.79M | €5.14M | €1.84M |
| Operating income | - | - | -€44.91M | -€32.24M | -€47.63M | - | - | - | - | - |
| Interest expense | €2.7K | €885 | €16.5K | €23.3K | €10.7K | €18.7K | -€22.3K | €0 | €4.92M | €2.05M |
| Pre-tax income | -€45.62M | -€46.06M | -€42.67M | -€29.48M | -€45.63M | -€33.98M | -€53.25M | -€29.81M | -€24.24M | -€8.94M |
| Income tax | €12.3K | €5.2K | - | - | €0 | €0 | €0 | €0 | €0 | €0 |
| Net income | -€45.63M | -€46.06M | -€42.67M | -€29.48M | -€45.63M | -€33.98M | -€53.25M | -€29.81M | -€24.24M | -€8.94M |
| EPS, basic | -€0.68 | -€0.78 | -€0.78 | -€0.67 | -€1.10 | -€1.26 | - | - | - | - |
| EPS, diluted | -€0.68 | -€0.78 | -€0.78 | -€0.67 | -€1.10 | -€1.26 | - | - | - | - |
| Diluted shares | 67.3M | 58.9M | 54.9M | 44.2M | 41.6M | 27.1M | 26.0M | 25.1M | 9.4M | 2,363 |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | €16.02M | €18.38M | €12.77M | €16.27M | €26.25M | €25.97M | €33.13M | €55.39M | €123.28M | €29.12M |
| Inventory | - | €6.90M | €11.37M | - | - | - | - | - | - | - |
| Current assets | €53.63M | €71.66M | €109.47M | €97.41M | €95.68M | €86.28M | €118.99M | €158.16M | €123.98M | €29.38M |
| Total assets | €55.22M | €76.02M | €120.21M | €102.40M | €125.14M | €88.22M | €121.58M | €159.21M | €124.21M | €29.52M |
| Current liabilities | €12.98M | €14.17M | €16.84M | €13.03M | €18.76M | €10.10M | €14.06M | €7.76M | €4.77M | €1.75M |
| Total liabilities | €13.66M | €14.60M | €17.63M | €14.05M | €19.86M | €10.35M | €14.43M | €7.82M | €4.78M | €55.21M |
| Shareholders' equity | €7.17M | €7.44M | €102.58M | €88.35M | €105.28M | €77.86M | €107.15M | €151.39M | €119.43M | -€25.69M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -€35.31M | -€48.56M | -€37.81M | -€33.74M | -€39.94M | -€36.53M | -€43.20M | -€21.55M | -€12.15M | -€4.99M |
| Capital expenditures | €115.7K | €46.9K | €81.1K | €162.4K | €37.8K | €94.2K | - | - | - | - |
| Free cash flow | -€35.43M | -€48.60M | -€37.89M | -€33.91M | -€39.97M | -€36.62M | - | - | - | - |
| Investing cash flow | €3.23M | €52.36M | -€17.70M | €19.36M | -€25.95M | €21.36M | €20.34M | -€99.45M | -€167.0K | -€53.0K |
| Financing cash flow | €33.32M | €386.4K | €52.99M | €1.94M | €61.58M | €9.17M | -€294.3K | €49.64M | €108.80M | €30.86M |
| Stock-based compensation | €4.44M | €4.07M | €3.41M | €6.04M | €4.33M | €1.12M | - | - | - | - |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -82.3% | 162.8% | - | -29570.3% | -87.7% | - | - | - | - | - |
| Gross margin | -24677.9% | -1900.8% | -743.7% | - | - | - | - | - | - | - |
| Operating margin | - | - | -71182.1% | - | -43545.5% | - | - | - | - | - |
| Net margin | -155582.1% | -27785.0% | -67630.7% | - | -41712.8% | -3828.3% | - | - | - | - |
| Free cash flow margin | -120793.8% | -29316.5% | -60064.5% | - | -36542.8% | -4125.5% | - | - | - | - |
| Return on equity | -636.3% | -619.1% | -41.6% | -33.4% | -43.3% | -43.6% | -49.7% | -19.7% | -20.3% | - |
| Return on assets | -82.6% | -60.6% | -35.5% | -28.8% | -36.5% | -38.5% | -43.8% | -18.7% | -19.5% | -30.3% |
| Current ratio | 4.13 | 5.06 | 6.50 | 7.48 | 5.10 | 8.54 | 8.46 | 20.39 | 26.01 | 16.83 |
Source: XBRL data InflaRx N.V. files with the SEC, latest filing dated Mar 20, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
IFRX peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| IFRX | €29.3K | -82.3% | -€45.63M | -155582.1% | $193.1M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.27T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $664.95B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $514.92B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $361.71B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $310.17B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $289.10B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $190.39B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $178.51B |
IFRX FAQ
9 questionsWhat is IFRX revenue?
InflaRx N.V. (IFRX) reported €29.3K of revenue for fiscal 2025 (ended Dec 31, 2025). That is down 82.3% from the year before.Is IFRX profitable?
No. InflaRx N.V. reported a net loss of €45.63M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does IFRX have?
InflaRx N.V. reported €16.02M in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is IFRX revenue growing?
InflaRx N.V.'s revenue changed -82.3% in fiscal 2025, to €29.3K. Its compound annual growth rate was -49.4% over 5 years.What is IFRX gross margin?
InflaRx N.V.'s gross profit was -€7.24M on €29.3K of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of -24677.9%.What is IFRX free cash flow?
InflaRx N.V. generated -€35.43M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -€35.31M less capital expenditures.What is IFRX earnings per share?
Diluted earnings per share were -€0.68 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did IFRX last report financial results?
The latest statements here come from InflaRx N.V.'s 20-F filed on Mar 20, 2026, covering the period ended Dec 31, 2025.Where does this IFRX financial data come from?
Quantisnow builds these statements from the structured XBRL data InflaRx N.V. files with the SEC. It is provided for information only and is not investment advice.